Ian Johnson - Bioquell plc Insider

Bioquell plc -- USA Stock  

USD 3.18  0.01  0.31%

Non-Executive Chairman of the Board

Mr. Ian Roy Johnson was appointed as NonExecutive Chairman of the Board of the Company, effective 10 June, 2016. Mr Johnson has spent his career working in a number of Life Sciences companies and is currently nonexecutive chairman of Cyprotex PLC and was formerly nonexecutive chairman of Celsis International Group as well as a nonexecutive director of MyCelx Technologies Corporationrationration.
Age: 62  Chairman Since 2016      
44 1264 835 900  http://www.bioquellplc.com

Management Efficiency

The company has return on total asset (ROA) of 5.32 % which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.16 % meaning that it generated $5.16 on every $100 dollars invested by stockholders.

Similar Executives

Found 1 records

CHAIRMAN Since

Manuel PangilinanMetro Pacific Investments Corpo
2006

Entity Summary

Bioquell PLC designs, manufactures, and supplies biodecontamination and containment equipment, and related solutions and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in Andover, SP TS and employs 226 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bioquell plc to your portfolio

Top Management

Bioquell plc Leadership Team
Ian Johnson, Chairman
Nigel Keen, Chairman
Nicholas Adams, Director
Christopher Mills, Director
Anthony Bourne, Director
Georgina Pope, Executive
Michael Roller, Director
Tony Bourne, Director
Ian Carruthers, Director
Simon Constantine, Director

Stock Performance

Bioquell plc Performance Indicators